Schedule 13D ownership disclosure

MEDI JECT CORP /MN/

Security class unavailable · CUSIP: 036642106

Event date: 2022-04-20

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.7300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-053860
Form type
SC 13D
Filer
ANTARES PHARMA, INC.
CIK
CIK 1016169
Filed
May 02, 2022
Reporting period
Apr 20, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub